190 related articles for article (PubMed ID: 30696584)
21. The stem cell division theory of cancer.
López-Lázaro M
Crit Rev Oncol Hematol; 2018 Mar; 123():95-113. PubMed ID: 29482784
[TBL] [Abstract][Full Text] [Related]
22. DSCP1, a novel TP53-inducible gene, is upregulated by strong genotoxic stresses and its overexpression inhibits tumor cell growth in vitro.
Hata T; Ogawa T; Yokoyama TA; Fukushige S; Horii A; Furukawa T
Int J Oncol; 2004 Mar; 24(3):513-20. PubMed ID: 14767535
[TBL] [Abstract][Full Text] [Related]
23. Induction of genetic instability by gain-of-function p53 cancer mutants.
Xu Y
Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
[TBL] [Abstract][Full Text] [Related]
24. p53 orchestrates between normal differentiation and cancer.
Rivlin N; Koifman G; Rotter V
Semin Cancer Biol; 2015 Jun; 32():10-7. PubMed ID: 24406212
[TBL] [Abstract][Full Text] [Related]
25. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
Mirzayans R; Andrais B; Kumar P; Murray D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
[TBL] [Abstract][Full Text] [Related]
27. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
28. p53 switches off pluripotency on differentiation.
Lin T; Lin Y
Stem Cell Res Ther; 2017 Feb; 8(1):44. PubMed ID: 28241890
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cancer stem cells by p53.
Jerry DJ; Tao L; Yan H
Breast Cancer Res; 2008; 10(4):304. PubMed ID: 18828866
[TBL] [Abstract][Full Text] [Related]
30. P53 tumor suppression network in cancer epigenetics.
Mishra A; Brat DJ; Verma M
Methods Mol Biol; 2015; 1238():597-605. PubMed ID: 25421682
[TBL] [Abstract][Full Text] [Related]
31. p53 and epithelial-mesenchymal transition: a linking thread between embryogenesis and cancer.
Sarig R; Tzahor E
Cell Cycle; 2011 Sep; 10(18):3036-7. PubMed ID: 21926472
[No Abstract] [Full Text] [Related]
32. Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2.
Ozaki T; Nakamura M; Shimozato O
Biomolecules; 2015 Oct; 5(4):2854-76. PubMed ID: 26512706
[TBL] [Abstract][Full Text] [Related]
33. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
34. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting.
D'Orazi G; Marchetti A; Crescenzi M; Coen S; Sacchi A; Soddu S
J Gene Med; 2000; 2(1):11-21. PubMed ID: 10765501
[TBL] [Abstract][Full Text] [Related]
35. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
Shah M; Allegrucci C
Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
[TBL] [Abstract][Full Text] [Related]
36. Polyploid giant cancer cells and cancer progression.
Zhou X; Zhou M; Zheng M; Tian S; Yang X; Ning Y; Li Y; Zhang S
Front Cell Dev Biol; 2022; 10():1017588. PubMed ID: 36274852
[TBL] [Abstract][Full Text] [Related]
37. p53 and its mutants on the slippery road from stemness to carcinogenesis.
Molchadsky A; Rotter V
Carcinogenesis; 2017 Apr; 38(4):347-358. PubMed ID: 28334334
[TBL] [Abstract][Full Text] [Related]
38. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
[TBL] [Abstract][Full Text] [Related]
39. p53 and human cancers.
Lane DP
Br Med Bull; 1994 Jul; 50(3):582-99. PubMed ID: 7987642
[TBL] [Abstract][Full Text] [Related]
40. The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder.
Yao Z; Sherif ZA
Oncotarget; 2016 Sep; 7(39):62976-62988. PubMed ID: 27542210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
